Supplemental Table

Published: 10 December 2021| Version 1 | DOI: 10.17632/kzg3xk4f5m.1
Contributor:
Gilles Battesti

Description

Details of the 3 and 6-month relapse rate according to the profile of immunological test results in the 116 patients with immunological tests performed at treatment cessation. ELISA+: ELISA BP180 at treatment cessation higher than the considered threshold value; ELISA-: ELISA BP180 at treatment cessation lower than the considered threshold value; DIF+: positive direct immunofluorescence at treatment cessation; DIF- : negative direct immunofluorescence at treatment cessation.

Files

Categories

Supplementation

Licence